Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 3.340
-0.110 (-3.19%)
Sep 11, 2026, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 2.27 billion as of September 11, 2026. Its market cap has decreased by -56.80% in one year.
Market Cap
2.27B
Enterprise Value
1.68B
Revenue
652.54M
Ranking
n/a
PE Ratio
34.40
Stock Price
3.34
ChartMarket Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 2.27B, a decrease of -81.43%. That is a compound annual growth rate of -25.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.27B | -11.87% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medtide | 2.82B |
| Viva Biotech Holdings | 2.74B |
| Beijing Luzhu Biotechnology | 2.69B |
| Laekna | 2.55B |
| Clover Biopharmaceuticals | 2.48B |
| Frontage Holdings | 2.40B |
| PegBio | 2.27B |
| AIM Vaccine | 2.09B |